戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  despite smaller body size and more uncommon blood groups (B, AB) among Indo-Asians.
2 ations that allow accommodation of fucose in blood group B active GH110 enzymes or, in the case of Pd
3    Escherichia coli O86 possesses high human blood group B activity because of its O-antigen structur
4 ipients of allograft expressing incompatible blood group B also produce anti-Gal B antibody, which bi
5 irmed RgGH98 affinity for blood group A over blood group B and H antigens.
6 dases that act equally well on both branched blood group B and linear alpha1,3Gal structures.
7 ng kidneys from A2 donors into patients with blood group B and O recipients has been used to alleviat
8 explanation for contrasts in associations of blood groups B and AB between CagA-endemic and -nonendem
9                                    The human blood group B antigen [Gal alpha1,3(Fuc1,2)Galactose] is
10                                          The blood group B antigen and linear alpha-Gal epitope can b
11 d to a series of oligomannose compounds, the blood group B antigen, and a fragment of beta-glucan rev
12 yme was active on Galalpha1-3Gal but not the blood group B antigen.
13 minant alpha1,3-linked galactose residues of blood group B antigens, we recently identified a novel p
14 uch as a decreased risk of kidney stones and blood group B as compared to blood group O.
15  have increased the transplantation rate for blood group B cadaveric waiting list candidates by trans
16 f its O-antigen structure, sharing the human blood group B epitope.
17 nhibitor for the donor binding site of human blood group B galactosyltransferase (GTB).
18 specificity of anti-alphaGal antibodies; (3) blood group B human and baboon sera have lower levels of
19 nsplantation, with longer waitlist times for blood group B kidney transplant candidates.
20 l cell surface polysaccharides by remodeling blood group B mimicry into blood group A mimicry.
21 e, particularly for patients with unknown or blood group B or AB types.
22                                     Those of blood group B or O may experience a significantly longer
23 the criteria mentioned below is present), of blood group B or O, and with diabetes are most at risk i
24   The median waiting times for patients with blood groups B or O were 1329 and 1007 days, respectivel
25 ted 15 A2 kidneys into 6 blood group O and 9 blood group B patients.
26 his binding preference, Gal-9 readily killed blood group B-positive Escherichia coli, whereas Gal-9N
27            This approach increases access of blood group B recipients to kidneys.
28  could improve access to transplantation for blood group B recipients.
29 re equal access to kidney transplantation in blood group B recipients.
30 e carbohydrate binding properties, including blood group B-specific agglutination and preferential bi
31                                            A blood group B-specific lectin from the mushroom Marasmiu
32 isite substrate specificity for the branched blood group B structure Galalpha1-3(Fucalpha1-2)Gal, whe
33  have exclusive specificity for the branched blood group B structures, whereas members of a newly ide
34 domain (Gal-9C) exhibiting higher binding to blood group B than the N-terminal domain (Gal-9N).
35                     The fucose moiety of the blood group B trisaccharide Galalpha1-3(Fucalpha1-2)Gal
36 Moreover, we found that the genetic-inferred blood group B was associated with a decreased risk (OR =
37               The known protective effect of blood group B was confirmed.